Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study

Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study

Source: 
Biopharma Reporter
snippet: 

The mRNA vaccine developed by Pfizer and BioNTech generates far higher levels of antibodies against the coronavirus than Sinovac’s inactivated virus prophylactic, according to a study.